Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC
Clinical trial NCT07743632 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07743632
- Sponsor
- University of Kansas Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2032-12-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.